Premium   
Epidemiology, risk factors, and prognosis of capillary leak syndrome in pediatric recipients of stem cell transplants: a retrospective single‐center cohort study
Author(s) - 
Lucchini Giovanna, 
Willasch Andre Manfred, 
Daniel Julia, 
Soerensen Jan, 
Jarisch Andrea, 
Bakhtiar Shahrzad, 
Rettinger Eva, 
Brandt Joerg, 
Klingebiel Thomas, 
Bader Peter
Publication year - 2016
Publication title - 
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/petr.12831
Subject(s) - medicine , cls upper limits , sepsis , single center , retrospective cohort study , incidence (geometry) , complication , cytokine release syndrome , transplantation , surgery , cohort , gastroenterology , disease , physics , covid-19 , optometry , infectious disease (medical specialty) , optics
CLS involves sudden loss of intravascular fluids into the interstitial spaces.  CLS  was described as a possible complication after  SCT . Few studies report the incidence of  CLS  in pediatric populations. We aimed to assess  CLS  incidence, its risk factors, and impact on the survival. The clinical charts of patients <18 years of age transplanted at our institution between 2002 and 2012 were reviewed.  CLS  was defined by weight gain >3% in 24 hours and positive intake balance despite furosemide administration. In total, 234 patients underwent 275 allogeneic  SCT  procedures in the analyzed time frame. Fifteen patients developed  CLS  (5.4%). The probability of developing  CLS  was significantly increased in patients suffering from sepsis (14.3% vs 0.6%,  P <.001). Patients with  CLS  exhibited an increased risk of acute Gv HD  in the first 30 days after  SCT  (10.8% vs 1.8%,  P =.002). Ten of the patients with  CLS  required intensive care.  CLS  strongly impacts OS at day +100 after  SCT  and is a predictive factor of TRM at the same date (42.9% vs 5%,  P <.0001). The biological relation among sepsis, Gv HD , and  CLS  development in terms of cytokine release and endothelial damage warrants further studies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom